Company Overview

Ostex International, Inc. engages in the development and commercialization of products to make ‘disease management a reality’, with osteoporosis being the first area of focus. Ostex’ lead product, the Osteomark® N-telopeptides of Type I collagen (NTx) test, incorporates breakthrough and patented technology for the management of osteoporosis. The Osteomark NTx test is a non-invasive test that quantitatively indicates the level of bone resorption. The company has collaborative relationships with laboratories and distributors, and markets its Osteomark NTx Point-of-Care device primarily to pharmaceutical companies to aid in the commercialization of its Osteomark technology. As of June 30, 2003,...

Ostex International, Inc. engages in the development and commercialization of products to make ‘disease management a reality’, with osteoporosis being the first area of focus. Ostex’ lead product, the Osteomark® N-telopeptides of Type I collagen (NTx) test, incorporates breakthrough and patented technology for the management of osteoporosis. The Osteomark NTx test is a non-invasive test that quantitatively indicates the level of bone resorption. The company has collaborative relationships with laboratories and distributors, and markets its Osteomark NTx Point-of-Care device primarily to pharmaceutical companies to aid in the commercialization of its Osteomark technology. As of June 30, 2003, Ostex International, Inc. operates as s subsidiary of Inverness Medical Innovations Inc.

Key Executives for Ostex International, Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions